2010

13 December 2010, Paris - France at 13th Workshop of the Eurordis Round Table of Companies

6-9 November 2010, Prague - Czech Republic at ISPOR Europe

Podium Presentations

  • view > Patient access schemes in UK are driven by Health Technology Assessment
  • view > Influence of HTA and hospital funding systems on patient access to innovating medicines: example of advanced renal cell cancer in Western Europe
  • view > Huntington quality of life interview (HQOLI): a new Huntington disease specific quality of life instrument

Workshop

  • view > How to address regional market access hurdles in decentralized European countries

Issue Panel

  • Rare (Orphan) disease: tension between government support of developing new therapies and reimbursement processes? Perspectives from EU-5 (Germany, UK, France, Spain and Italy), Central East Europe, USA and Canada.

Posters

  • view > Impact of methodological choices and assumptions in economic evaluations of rotavirus vaccination
  • view > Value of congress abstracts of cost-effectiveness studies for decision makers
  • view > Market access agreements in Europe: typology and rationale
  • view > Healthcare organizations/services clustering: example of PCTs in England
  • view > European-HD burden study (Euro-HDB) – preliminary results for Italy and France
  • view > Quality of life of caregivers in Huntington’s disease – first results from Euro-HDB study
  • view > Utilization of antiemetic prophylaxis alongside chemotherapy in four European countries
  • view > Cost-effectiveness of memantine in the treatment of moderate to severe alzheimer’s disease patients with agitation, aggression and psychosis – the UK example

 3-5 September 2010, Prague - Czech Republic at European Huntington Disease Network

Posters

  • view > Huntington quality of life interview (HQOLI): a new Huntington disease specific quality of life instrument
  • view > European-HD burden study (Euro-HDB) – preliminary results for Italy and France

 5-7 September 2010, Phuket – Thailand at ISPOR Asia and Pacific

Poster

  • PDB27 - A review of health technology assessments of diabetes in Asia and Oceania
    Available upon request

13-17 June 2010, Buenos Aires – Argentina at the 14th International Congress of Parkinson's Disease and other Movement Disorders

Poster

  • view > European-HD burden study (Euro-HDB) – preliminary results for Italy and France

4-8 May 2010, Nice – France at ESPID Annual Meeting 2010

Poster

  • view > A critical review of economic models of rotavirus vaccination

 15-19 May 2010, Atlanta – USA at ISPOR International

Podium presentation

  • view >  Variability in utilization of innovative drugs in Europe as a result of health technology assessment and funding procedures: examples of trastuzumab and cetuximab

Posters

  • view > Quantitative analysis of the influence of disease and product characteristics on orphan drug prices in Europe
  • view > Influence of health technology assessments on utilization of bevacizumab in Europe

     

 

Archives